RaQualia Pharma Inc. (TYO:4579)
Japan flag Japan · Delayed Price · Currency is JPY
503.00
+9.00 (1.82%)
Aug 6, 2026, 1:54 PM JST

RaQualia Pharma Cash Flow Statement

Millions JPY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
52.64437-357-294851880
Depreciation & Amortization
481.71487401175147141
Loss (Gain) From Sale of Investments
---3-35-16
Other Operating Activities
-7.71-131-100-128-203-81
Change in Accounts Receivable
-78.48-1,239-85-603-674
Change in Inventory
-1.3973-1392-4
Change in Accounts Payable
2.0176-98-134111136
Change in Other Net Operating Assets
-213.619419-198-66-16
Operating Cash Flow
203.17-354180-7181,480366
Operating Cash Flow Growth
-30.36%---304.37%-

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-66.16-67-96-205-31-92
Cash Acquisitions
-120--3,879---
Sale (Purchase) of Intangibles
-7.52-7-19-17--13
Investment in Securities
53.1720015890-15-174
Other Investing Activities
-3.89-2171-3-1-
Investing Cash Flow
-144.39124-3,665-135-47-279

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--400--10
Long-Term Debt Issued
--3,3575013-
Total Debt Issued
--3,757501310
Short-Term Debt Repaid
---400---10
Long-Term Debt Repaid
--512-387-11-2-
Total Debt Repaid
-590.25-512-787-11-2-10
Net Debt Issued (Repaid)
-590.25-5122,9703911-
Issuance of Common Stock
2,4211,0198080541
Other Financing Activities
-2.2-129-68-51-44-17
Financing Cash Flow
1,8293782,982793-29-16

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
42.69-45-204535109
Miscellaneous Cash Flow Adjustments
0-111-1-1
Net Cash Flow
1,930102-522-141,438179

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
137.01-42184-9231,449274
Free Cash Flow Growth
-32.88%---428.83%-
Free Cash Flow Margin
3.59%-10.58%2.70%-48.55%49.66%9.87%
Free Cash Flow Per Share
5.49-17.503.88-42.7269.0613.06
Levered Free Cash Flow
85.83-485415.63-6941,17264.88
Unlevered Free Cash Flow
123.17-448.13441.88-689.631,17665.5

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
59.725942661
Cash Income Tax Paid
210.7113810010918376
Change in Working Capital
-344.79-1,147239-471650-558